Resource Use Up With Supervised Visits in Emergency Room

This article originally appeared here.
Share this content:
Resource Use Up With Supervised Visits in Emergency Room
Resource Use Up With Supervised Visits in Emergency Room

TUESDAY, Dec. 9, 2014 (HealthDay News) -- Resource use is increased for supervised visits, involving both resident and attending physicians, in the emergency department, according to a study published in the Dec. 10 issue of the Journal of the American Medical Association, a theme issue on medical education.

Stephen R. Pitts, M.D., M.P.H., from the Emory University School of Medicine in Atlanta, and colleagues compared resource use in supervised versus attending-only visits in a sample of patient visits to U.S. emergency departments. Data were collected from the National Hospital Ambulatory Medical Care Survey (2010) for 29,182 visits to 336 nonpediatric emergency departments.

The researchers found that 3,374 of the visits were supervised, and these were significantly associated with more frequent hospital admission (adjusted odds ratio [aOR], 1.42; 95 percent confidence interval [CI], 1.09 to 1.85), advanced imaging (aOR, 1.27; 95 percent CI, 1.06 to 1.51), and a longer median emergency department stay (adjusted geometric mean ratio, 1.32; 95 percent CI, 1.19 to 1.45), but not with blood testing (aOR, 1.18; 95 percent CI, 0.96 to 1.46), compared with attending-only visits. In major teaching emergency departments, supervised visits were not associated with hospital admission, advanced imaging, or any blood test, but were associated with longer emergency department stays (adjusted geometric mean ratio, 1.32; 95 percent CI, 1.14 to 1.53), compared with attending-only visits.

"In a sample of U.S. emergency departments, supervised visits were associated with a greater likelihood of hospital admission and use of advanced imaging and with longer emergency department stays," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »